Timo Liebig

Timo Liebig is a Chief Science Officer with extensive experience in the biopharmaceutical industry. Timo has a background in bioassay development, project management, and regulatory affairs. Liebig has held various leadership roles in companies such as Alvotech and Celonic AG, overseeing CMC research and development activities for biosimilar products. Timo holds a PhD in Biomedical Sciences and a Diploma in Biology, along with a postgraduate degree in Regulatory Affairs for Biopharmaceuticals. Liebig's expertise lies in strategic planning, project management, and technical development within the biopharmaceutical sector.